LYVE-1, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG

Search, find, compare suppliers for anti-LYVE-1, Human antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityLYVE-1, Human
CloneREAL1161
Host SpeciesRecombinant Human
Reactive Specieshuman
Isotypen/a
Formatfluorescein (FITC) conjugate
Size200 µL
Concentrationn/a
ApplicationsMICS (MACSima Imaging Cyclic Staining), Immunohistochemistry, Immunofluorescence
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionLYVE-1 Antibody, anti-human, FITC, REAdye_lease™. Clone REAL1161 is an antibody fragment derived from the full LYVE-1 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL1161 recognizes the human LYVE-1 protein, also known as lymphatic vessel endothelial hyaluronic acid receptor 1, LYVE1, XLKD1 or CRSBP-1. LYVE-1 is a type I integral membrane glycoprotein, which is a lymph-specific receptor for hyaluronan and homologous to CD44. LYVE-1 is mainly expressed in endothelial cells lining lymphatic vessels, but also in normal hepatic blood sinusoidal endothelial cells. LYVE-1 is an indicator for human hepatocellular carcinoma. It is involved in lymphatic hyaluronan transport, in tumor metastasis and autocrine regulation of cell growth. Lyve-1 is expressed in liver cancer. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). |
Immunogenn/a
Other NamesLYVE1, CRSBP-1, CRSBP1, HAR, XLKD1
Gene, Accession #n/a
Catalog #130-128-001
Price$385
Order / More InfoLYVE-1, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Product Specific ReferencesBanerji, S. et al. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J. Cell Biol. 144 (4): 789-801. | Mouta Carreira, C. et al. (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res. 61 (22): 8079-8074. | Rinaldi, E. et al. (2018) LYVE-1 is 'on stage' now: an emerging player in dendritic cell docking to lymphatic endothelial cellsElena Rinaldi and Fulvio Baggicorresponding author. Cell. Mol. Immunol. 15 (7): 663-665.
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-Straße 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197

macs@miltenyibiotec.de

https://www.miltenyibiotec.com

Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.